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Microparticulate systems of nimesulide (NIM) were prepared by
modified solvent evaporation method using different variables such
as polymer: drug (NIM) ratios (cellulose acetate, CA: nimesulide,
NIM) (1:9, 1:6 and 1:3), agitation speeds (500-1500 rpm) and
stirring time (15-30 min). The effects of processing variables were
evaluated by microparticle size and entrapment efficiency. The
average microparticle size increases from 66.8±1.45 to
87.3±1.06 µm with increase in the polymer concentration while
reduces with increase in agitation speed and stirring time; but at
the too higher speed gives irregular shape of particles. The highest
entrapment efficiency (77.83±0.51%), size uniformity, free
flowability, i.e., angle of repose (23.5±0.4º) and compressibility
index (14.2±0.6%), of microparticles were found with 1:6 (polymer:
drug ratio), at 1000 rpm and 20 min stirring time among all
prepared microparticles (P ≤ 0.05). The in-vitro drug release study
of microparticles with optimized processing variables (agitation
speed and time) were carried out and compared with conventional
and marketed SR tablets. The conventional tablet releases
maximum drug within 4 h while microparticulate system releases
more than 14 h. All formulations followed first order release kinetic
and diffusion controlled drug release (Higuchi model). These
microparticles are stable at room temperature (25±1 °C) but
agglomerate at elevated temperature (50±1 °C) by softening and














Microencapsulation is a well known method for the
preparation of controlled or extended release dosage forms.
Different coating materials and processes are used for
microencapsulation of drugs. The literature reviews
showed the different criteria for the designing of
microparticles according to polymer properties (Bayomi
2004; Sajeev et al., 2002). Cellulose acetate (CA) is a
water insoluble cellulosic polymer and commonly used for
the formulations of microparticles, pellets and beads for the
delivery of prolonged and sustained therapy (Soppimath et
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al., 2001). In the present work cellulose acetate (CA) is
chosen as suitable polymer for encapsulating the
nimesulide by solvent evaporation technique. Nimesulide
(NIM) is described chemically as N-(4-nitro-2-
phenoxyphenyl)methane sulfonamide. It is a unique non-
steroidal anti-inflammatory (NSAID) agent having specific
affinity to inhibit cyclooxygenase-2 enzyme (Rabasseda
1992). It is highly effective in reducing pain associated with
osteoarthritis, rheumatoid, and other degenerative joints
disorders, low back pain, dysmenorrhoea, gynaecological
condition, thrombophlebitis, dental pain and inflammations
etc. (Bernareggi, 1993; Kulkarni, 2002). This drug is also
associated with some severe side effects due to higher do-
ses such as epigastric pain, heartburn, nausea, diarrhoea,
vomiting, peptic ulcer and hepatic impairments. Nimesulide
attain peak serum concentrations of 1.98 to 9.85 mg/L
within 1.22 to 3.17 hours when given orally and extensively
bound to plasma proteins (99%) having half-life 1.56 to
4.95 hr which requires frequent dosing to maintain plasma
concentration (Boelsterli, 2002; Peruccae, 1993; Singla et
al., 2000). The objective of this study is to develop
sustained release formulation with lower dose of drug to
maintain plasma concentration that may increase patients
compliance, improved therapeutic efficacy and reduced
severity of upper GI side effects because of alteration in




Nimesulide B.P. received as gift sample from
Nicholas Piramal India Ltd, Pithampur M.P.), cellulose
acetate from Zeim Lab. Nagpur. The chemicals such as
acetone, methanol, liquid paraffin (heavy and light) and n-
hexane, were of analytical grade supplied by Merck Chem.
Ltd.
Preparation of microparticles
NIM microparticles were prepared by using cellulose
acetate polymer as a retardant material and any interaction
to the drug was studied by IR spectra.
The microparticles of nimesulide were prepared by
modified emulsion solvent evaporation method with
modifications (Olive, Rey, 1993; Chowdhary, Ramesh,
1995; Saravanan et al., 2003; Saraf et al., 2006; Dashora
et al., 2006a) using polymeric solution (CA) with the
different polymer: drug ratio (1:9, 1:6 and 1:3) in 10 mL
acetone. This solution was dispersed in a thin stream to
previously heated liquid paraffin (1:1 light and heavy,
600 mL at 60±3 °C) in a 1000 mL beaker with stirring rate
at 500-1500 rpm. A Remi medium duty stirrer was used for
stirring and continued for 15 - 30 minutes to disperse the
added mixture as fine droplet emulsion. The solvent was
removed by evaporation at room temperature (30 ±1 °C)
under vacuum (0.80 torr) for 1.0 hour to produce almost
spherical microparticles (projection microscope, Quasmo,
India). The microparticles were collected by decantation
and washed with n-hexane to remove adhering liquid
paraffin. The product was then dried to obtained discreet
microparticles. Microparticles were prepared using
different polymer: drug ratios 1:9,1:6 and 1:3 (NIM-1,
NIM-2 and NIM-3), while keeping the other two variables
constant i.e. stirring speed 1000 rpm and stirring time
20 min. Similarly, microparticles were also prepared at
different stirring rate viz. 500, 1000 and 1500 rpm, keeping
the polymer: drug ratio 1:6 and stirring time 20 min. In the
same way microparticles were prepared using different
stirring time i.e. 15, 20 and 30 min, keeping the polymer:
drug ratio 1:6 and stirring speed 1000 rpm.
Characterization of microparticles
Infrared spectra of NIM and NIM loaded
microparticles were determined in the range of 4700 to
400 cm-1 using a Fourier-transform infrared spectro-
photometer (FT-IR) (model FTIR-8400 S Shimadzu,
Japan) from KBr pellets.
The surface morphology of microparticles was
performed by a scanning electron microscopy (SEM, LEO
430, London). Microparticles were mounted on stubs and
coated for 120 s with a layer of gold using a sputter coater.
The size of microparticles was determined by an optical
microscopy using a calibrated ocular micrometer (Erma,
Japan).
Stability studies were conducted to find out stable
product under storage. The microparticles were stored in
amber colored glass bottles at elevated temperature i.e.,
4±1 °C freezing temperature (FT), 25±1 °C room
temperature (RT) and 50±1 °C hot temperature (HT) for a
period of 30 days and observed for change in drug content
and morphology, i.e. shape and structural integrity, by
microscopic and scanning electron microscopy.
Drug content
After stipulated time of storage, an accurate weighed
quantity of microparticles (200 mg) was taken and finely
powdered. The powdered amount equivalent to 50 mg of
NIM was extracted in 10 mL methanol and 20 mL of
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pH 6.8 buffer. The insoluble polymer was separate out
through the Whatman (0.45 µm) filter paper. The
supernatant was assayed spectrophotometrically (UV-1700
- Shimadzu Japan) after suitable dilution at 397nm by using
modified method of Dashora et al. (2006b). The percentage
of nimesulide remained was calculated by using equation
(A=0.3474 Conc. + 0.0353, R2=0.999, where A and R2
indicates absorbance of test solution in phosphate buffer of
pH 6.8 and regression coefficient of calibration curve of
nimesulide respectively). Each determination was made in
triplicate.
Entrapment efficiency of microparticles
An accurately weighed quantity of microparticles
(equivalent to 50 mg NIM) was extracted in 10 mL
methanol and 20 mL of pH 6.8-phosphate buffer for 24 h.
Coating polymeric material is separated out through the
Whatman (0.45 µm) filter paper. The polymer was washed
three times (7 mL each time) with buffer and all filtrates
were added and assayed spectrophotometrically (UV-1700-
Shimadzu Japan) after suitable dilution at 397 nm. The
concentration of drug in filtrate was determined from the
calibration curve of NIM in alkaline phosphate buffer
pH 6.8 and encapsulation efficiency for microparticles was
calculated by using equation (A=0.3474 Conc. + 0.0353,
R2=0.999, where A and R2 indicates absorbance of test
solution in phosphate buffer of pH 6.8 and regression
coefficient of calibration curve of nimesulide respectively).
Each determination was made in triplicate.
Flow properties of the microparticles were evaluated
by determining the angle of repose by fixed funnel and free
standing cone method and the compressibility index by
tapped density method.
Drug release studies
The USP method II or paddle dissolution test (Model
No. USP TDT –06P, Electrolab), was used with a pH 6.8
phosphate buffer as the release medium. The stirring speed
was 100 rpm and the temperature of the release medium
was kept at 37±0.5 °C. An accurately weighed amount of
microparticles equivalent to 100 mg of NIM was added to
900 mL of dissolution medium and methanol was included
in the dissolution medium to provide a sink condition, in
order to kept the drug below the 10% of the saturation value
(Dashora et al., 2006c). At programmed intervals, 5 mL
samples were withdrawn and filter through 0.45 µm
Whatman filter and assayed spectrophotometrically at
397 nm using modified method after suitable dilution
(Dashora et al., 2006b). An equivalent quantity of
dissolution medium was added at all the withdrawal of
sample. The mean of six determinations was used to
calculate the drug release from each of the formulation.
Release kinetics
In the present study, two different mathematical
equations (Martin, 1983) were employed to model the
dissolution profile from the NIM microparticles system i.e.,
(1) first order equation; (2) Higuchi’s square root of time
equation.
(1) First order model can be expressed as
Mt / M∞ = 1- e
- k1
t
(2) Higuchi’s square root of time model is given by
Mt / M∞ = kH t
1/2
Where Mt is the amount of drug released at time t, M∞
is the maximal amount of drug released at infinite time, k1
and kH are the rate constants for first order and Higuchi
model, respectively.
RESULTS AND DISCUSSION
In order to study the interaction between NIM and
polymer (CA), IR studies were performed using KBr pellet
press method. The IR spectra of the NIM indicated the
presence of bands at about 900-640 cm-1 (C-H aromatic),
1080 cm-1 (S=O), 1160 cm-1 (C-O-C ether linkage),
1140 cm-1(CH3 C-H bending), 1520 and 1350 cm-1 (NO2),
2940 cm-1 (CH3 C-H stretching) and 3280 cm-1 (N-H). IR
spectra of NIM loaded microparticles of CA also showed
the peaks at the same bands. This indicated that there is no
interaction between NIM and polymers employed in the
microparticles.
The effect of various processing variables of
microparticles like polymer concentration, agitation speed
and stirring time were studied on particle size, drug
entrapment efficiency and drug release study. When
polymer concentration was increased from 1:9 to 1:3
(polymer: drug) ratio then particle size increases from
68.8±1.45 to 87.33±1.06 µm. The average diameter of the
microparticles at various agitation speeds i.e., 500, 1000
and 1500 rpm were found in decreasing order, i.e.,
71.1±1.63 to 69.1±1.05 µm (Table I). This suggests that
the size of the droplets formed during microcapsulation is
closely related to the size of final microcapsules, which
increased by decreasing the stirring speed. A faster stirring
speed 1500 rpm gave much smaller but cohered particles.
At lower speed (500 rpm), the mean particle diameter and
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size distribution of the microparticles increased
considerably. The irregularity in shape of microparticles
occurred at higher speed (1500 rpm) but discreet and
uniform size of microparticles were obtained at 1000 rpm.
The average diameter of the microparticles decreases from
78.4±2.05 to 68.23± 0.87 µm on increasing stirring times
from 15 to 30 min. The short time (15 min) resulted in
aggregates and less discreet microparticles where at high
stirring time (30 min) resulted smaller microparticles with
increased size distribution. The discreet and uniform size of
the microparticles was found at 20 min stirring time.
The maximum entrapment efficiency (75.66±1.86%)
was found for NIM-2 formulation. This may be due to that
at this polymer: drug ratio, uniform size of drug globules
coated with polymer during emulsification process
[observed under projection microscope (Quasmo, India)].
The agitation speed affects drug entrapment efficiency of
microparticles and it were found to be 73.66±3.15,
77.63±1.81  and  72.71±3.40 with 500-1500 rpm
respectively. The lower entrapment efficiency at 500 rpm
agitation speed may be due to inadequately stirring of
droplets, which leads to increased chances of coalescence.
At higher agitation speed i.e., 1500 rpm, it was visually
observed that most of the globules were forced towards the
wall of the flask due to high rotation and it lowers the
contact time between polymer and drug molecules. But at
1000 rpm, no sticking of polymeric material around the
walls of flask was visually observed which may leads to
improved drug: polymer contact time resulting highest drug
entrapment efficiency. The effect of varying stirring time
(15-30 min) was also observed for drug entrapment
efficiency and found 70.66±1.83 and 73.46±1.95% at
lower and higher stirring time. The maximum entrapment
efficiency (77.83±0.50%) was observed at stirring time
20 min because of sufficient time for tightening of
polymeric network around the globules unlike in case of
lower and higher stirring time (Table I). The data of
entrapment efficiency indicates that approx 23% of the
drug appears to leach out to the external phase (liquid
paraffin) during the process and it is confirmed by
estimation of residual drug content in external phase. So,
microparticles which prepared under optimized conditions
i.e., polymer: drug ratio 1:6, agitation speed 1000 rpm and
stirring time 20 min were found to be spherical in shape,
uniform in size and exhibited a smooth surface. The
uniform size and smooth surface of microparticles was due
to the tightening of the polymeric net work leading to
shrinkage of the microcapsules as the time of evaporation
of solvent increased. The optimum size of microcapsules
were obtained with 20 min stirring time because larger time
30 min gave smaller microparticles and shorter time 15 min
gave aggregated and less discreet microparticles. The
surface morphology of microparticles prepared under
optimized conditions was shown in Figure 5.
Data of average diameter and entrapment efficiency
of all CA microparticles were compared (SSPS soft ware)
to each other statistically using unpaired t-test and one-way
analysis of variance (ANOVA) at a significant level
P ≤ 0.05.
The flowability of microparticles was determined in
terms of angle of repose and compressibility index (Table
III) for its application in fabrication of sustained products.
TABLE I - Effects of processing variables on the characteristics of cellulose acetate microparticles containing nimesulide
(Mean ± sd, n=3)
Variables/Factor Parameter Particle size (average diameter) (µm)d Entrapment efficiency (%)d
Polymer: drug ratioa 1:9 68.8±1.45 70.31±1.05
1:6 71.1±0.81 75.66±1.86
1:3 87.3±1.06 66.46±2.08
Stirring speed (rpm)b 500 71.1± 1.63 73.66±3.15
1000 70.2± 1.05 77.63±1.81
1500 69. 1± 1.05 72.71±3.40
Stirring time (min)c 15 78.4±2.05 70.66±1.83
20 71.2±1.95 77.83±0.51
30 68.23±0.87 73.46±1.95
aAt stirring rate 1000 rpm and stirring time 20 min; b At polymer: drug ratio 1:6 and stirring time 20 min; c At Polymer: drug
ratio 1:6 and stirring speed 1000 rpm; d Data of average diameter and entrapment efficiency of CA microcapsules were
compared statistically using unpaired t-test and one-way analysis of variance (ANOVA) at a significant level P ≤ 0.05
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The angle of repose was found in the range of 23.5±0.4 to
34.4 ± 0.6º and compressibility indices in the range
13.8±0.7 to 23.6±0.6% % suggesting good flowability of
particles (Banker, Anderson, 1986).
The release studies of all microparticles (NIM-1 to
NIM-3) were carried out by dissolution data in phosphate
buffer pH 6.8. It is calculated as cumulative percent drug
release and compared with conventional tablet (Figure 1).
The cumulative percentage drug release in the formulation
NIM-1, NIM-2, NIM-3 and conventional tablet (Con. tab.)
was found to be 96.29±1.35, 94.21±1.21, 86.23±1.13 and
93.29±0.52 respectively. The drug release from conventional
tablet was exhausted within 4 h while microparticles
sustained the drug more than 14 h. The study showed that
cumulative percentage drug release is influenced by the
microparticle size in all formulation and increase in release
with decrease in microparticles size. This may be due to the
presence of more drug molecules close to their surface in
smaller particles for dissolution in the surrounding medium
as compared to larger microparticles. In- vitro drug release
data showed that 65.36± 2.16 – 72.41± 1.89, 54.36± 2.34 –
64.29± 1.48% nimesulide were released from NIM-1 and
NIM-2 formulations respectively within 4-6 h while only
42.56± 1.68 – 54.89± 2.14 nimesulide was released from
NIM-3 formulation. To observe the kinetic of drug release,
the logarithm of percent drug retained in microparticles
versus time was plotted and found straight line (Figure 2). It
indicates that all microparticles follows first order release
rate kinetic pattern (Table II). The first order regression
equation and coefficient was shown in Table II. The
FIGURE 2 - First order kinetics of nimesulide
microparticles.
NIM-1: Nimesulide microparticles of1:9 polymer: drug
ratio; NIM-2: Nimesulide microparticles of 1:6 polymer:
drug ratio; NIM-3: Nimesulide microparticles of 1:3
polymer: drug ratio
TABLE II - Regression equation, regression co-efficient and first order release rate of cellulose acetate microparticles
containing nimesulide
S. No. Formulation Polymer: Regression Release Rate Equations b Regression
Drug Ratio coefficient (r2)a Constant K1 %(hr-1) coefficient (r2)c
1 NIM-1 1:9 0.9891 0.290 Y = - 0.1263X+2.0605 0.9474
2. NIM-2 1:6 0.9910 0.225 Y = - 0.0977X+2.0513 0.9787
3. NIM-3 1:3 0.9805 0.152 Y = -0.0663X+2.0107 0.9870
a Higuchi’s regression coefficients; bFirst order regression coefficients; cFirst order kinetic equations
FIGURE 1 - Release profile of nimesulide from
microparticles and conventional tablets.
NIM-1: Nimesulide microparticles of1:9 polymer: drug
ratio; NIM-2: Nimesulide microparticles of 1:6 polymer:
drug ratio; NIM-3: Nimesulide microparticles of 1:3
polymer: drug ratio; Con.Tab.: Marketed conventional
tablets of nimesulide
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dissolution data of all microparticles were fitted in Higuchi’s
model and found, that was linear (r2 value, Table II)
indicating diffusion controlled release from the polymer (Fi-
gure 3).
The value of Higuchi’s regression coefficient (r) of
NIM-2 formulation was found to be more linear (0.9910)
than NIM-1 and NIM-3 formulation (Table II), and also
maximum entrapment efficiency were obtained as
compared to NIM-1 and NIM-3 microparticles (Table II).
In vitro release data of NIM-2 microparticles were
compared with available SR tablets as marketed reference
in order to check the feasibility of prepared formulation for
the further development of suitable and convenient multiple
unit dosage forms with appropriate loading and
maintenance dose. The in vitro data showed that NIM-2
microparticles have slower release (K1= 0.225% h
-1) than
marketed SR tablet (K1= 0.371% h
-1). So NIM-2
microparticulate formulation may be utilized for the more
extended period of drug release as a maintenance dose.
In order to make stable sustained product, the
stability studies showed that microparticles are stable at
4±1°C (RT), 25±1°C (RT) and 50±1°C (HT). The
percentage residual drug content of the NIM-1, NIM-2 and
NIM-3 microparticles were shown in Table IV at 4±1°C to
50±1°C after 7, 15 and 30 days of storage (Figure 4). No
significant differences in percent residual drug content were
observed at ambient and accelerated storage conditions in
the prepared formulation indicating all formulations were
stable under the stability studies.
CONCLUSION
The study concluded that the processing variables;
polymer: drug ratio, agitation speed and stirring time affects
the preparation of sustained release nimesulide
microparticles by an emulsion solvent evaporation process.
FIGURE 3 - Higuchi square root of time model for NIM-
1, NIM-2 and NIM-3 microparticles.
NIM-1: Nimesulide microparticles of1:9 polymer: drug
ratio; NIM-2: Nimesulide microparticles of 1:6 polymer:
drug ratio; NIM-3: Nimesulide microparticles of 1:3
polymer: drug ratio
TABLE III - Angle of repose and compressibility index of nimesulide microparticles (Mean± SD, n=3)
S.No. Polymer Formulation Polymer: Angle of repose Compressibility
Drug Ratio θ (degree) Index (I) (%)
1 NIM-1 1:9 34.4±0.6 23.6±0.6
2 Cellulose acetate NIM-2 1:6 23.5±0.4 14.2±0.6
3 NIM-3 1:3 25.6±0.3 13.8±0.7
FIGURE 4 - Stability studies of nimesulide microparticles
at 4±1 (FT), 25±1 (RT), 50±1 (HT) °C after 0, 7, 15 and 30
days storage.
NIM-1: Nimesulide microparticles of 1:9 polymer drug
ratio; NIM-2: Nimesulide microparticles of 1:6 polymer
drug ratio; NIM-3: Nimesulide microparticles of 1:3
polymer drug ratio
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These variables not only influenced the morphology (Figu-
re 5) but also affects on release of drug from the
microparticles. The cellulose acetate could be a suitable
polymer to give diffusion-controlled sustained formulation of
nimesulide. Such sustained microparticles can also provide
the flexibility to develop suitable dosage form for desired
period of drug delivery as compared to available SR
marketed formulation. Thus, it may improve safety, efficacy
and patient compliance with reduced common cause of
problem due to high dose absorption at once in conventional
tablet.
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RESUMO
Efeito de variáveis do processo e estudo in vitro de
sistema microparticulado de nimesulida
Prepararam-se sistemas microparticulados de nimesulida
(NIM) pelo método modificado de evaporação do solvente
usando diferentes variáveis, tais como proporções
polímero fármaco(NIM) (acetato de celulose, CA:
nimesulida, NIM) (1:9, 1:6 e 1:3), velocidades de agita-
ção (500-1500 rpm) e tempo de agitação (15-30 min). Os
efeitos das variáveis do processo foram avaliados pelo ta-
manho da partícula e pela eficiência no encapsulamento.
O tamanho médio das micropartículas aumenta de
66,8±1,45 a 87,3±1,06 µm com o aumento na concentra-
ção de polímero, enquanto reduz com o aumento da velo-
cidade e do tempo de agitação, mas velocidades mais al-
tas resultam em partículas de formas irregulares. A eficá-
cia de encapsulamento mais alta (77,83±0,51%), unifor-
midade de tamanho, fluxo livre, isto é, ângulo de repou-
so (23,5±0,4º), e índice de compressibilidade
(14,2±0,6%), das micropartículas foram encontrados com
a proporção de 1:6 (polímero:fármaco), a 1000 rpm e 20
min de tempo de agitação entre todas as micropartículas
TABLE IV - Percentage of nimesulide after stability studies of microparticles at 4±1 (FT), 25±1(RT), 50±1(HT) °C
Storage Study at 4±1°C(FT) Study at 25 ±1°C(RT) Study at 50±1°C(HT)
(days) Percentage of nimesulide
NIM-1 NIM-2 NIM-3 NIM-1 NIM-2 NIM-3 NIM-1 NIM-2 NIM-3
0 100 100 100 100 100 100 100 100 100
7 98.22 98.65 98.79 98.44 98.74 98.79 98.02 98.74 98.57
±0.38 ± 0.27 ±0.23 ±022 ±0.38 ±0.39 ±0.34 ±0.38 ±0.28
15 98.12 98.21 98.56 98.36 98.45 98.39 98.21 98.38 98.23
±0.18 ±0.64 ±0.22 ±0.37 ±0.65 ±0.18 ±0.37 ±0.46 ±0.31
30 97.89 97.68 97.85 98.89 97.35 97.98 97.56 97.28 97.56
± 0.69 ±0.97 ± 0.44 ±0.12 ±0.22 ±0.54 ± 0.41  ±0.57 ± 0.82
FIGURE 5 - Scanning electron micrograph of nimesulide
microparticles (1:6 polymer: drug ratio)
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preparadas (P ≤ 0,05). O estudo da liberação do fármaco
das micropartículas in vitro com variáveis do processo
otimizadas (velocidade de agitação e tempo) foi desenvol-
vido e comparado com comprimidos convencionais e
comercializados SR. O comprimido convencional libera o
máximo de fármaco dentro de 4 h enquanto o sistema
microparticulado libera em mais que 14 h. Todas as for-
mulações seguiram cinética de liberação de primeira or-
dem e liberação do fármaco controlada pela difusão (mo-
delo de Higuchi). Estas microparticulas são estáveis à
temperatura ambiente (25±1 oC), mas se aglomeram a
temperaturas elevadas (50 ± 1 oC) por meio do amoleci-
mento e fusão do polímero observada sob o estudo SEM.
UNITERMOS: Acetato de celulose. Micropartículas.
Nimesulida.
REFERENCES
BANKER, G.S.; ANDERSON, N.R., Tablets. In:
LACHMAN, L.; LIBERMAN, H.A.; KANIG, J.I.,
(Eds). The theory and practice of industrial pharmacy.
Philadelphia, Lea and Febiger Publishers, 1986. p. 293-
345.
BAYOMI, M.A. Aqueous preparation and evaluation of
albumin-chitosan microspheres containing indomethacin.
Drug Dev. Ind. Pharm., v. 30, n. 4, p. 329-339, 2004.
BERNAREGGI, A. The pharmacokinetic profile of
nimesulide in healthy volunteers. Drugs, v. 46, p. 64-72,
1993.
BOELSTERLI, U.A. Mechanisms of NSAID-induced
hepato-toxicity: focus on nimesulide. Drug Saf., v. 25, n.
9, p. 633 - 648, 2002.
CHOWDHARY, K.P.R.; RAMESH, KV.R.N.S.
Microencapsulation of solid dispersions of nifedipine-
novel approach for controlling drug release. Indian Drug,
v. 32, n.10, p. 477, 1995.
DASHORA, K.; SARAF, S.; SARAF, S. In-vitro studies of
tizanidine hydrochloride controlled release microcapsular
matrices. Pak. J. Pharm. Sci., v. 19, n. 3, p. 177-181,
2006a.
DASHORA, K.; SARAF, S.; SARAF, S. Simultaneous
spectrophotometric method for the determination of
nimesulide and tizanidine hydrochloride. Orient. J. Chem.,
v. 22, n. 1, p.167-168, 2006b.
DASHORA, K.; SARAF, S.; SARAF, S. Effect of processing
variables on micro particulate system of nimesulide. The
Chinese Pharm. J., v. 58, p. 67-74, 2006c.
KULKARNI, S.K. On the safety of nimesulide, a preferential
COX-2 inhibitor. Curr. Sci., v. 83, n.12, p.1442-1443,
2002.
MARTIN, A. Physical pharmacy. Philadelphia: Lea and
Febiger Publishers, 1983. p. 414.
OLIVE, G.; REY, E. Effect of age and disease on the
pharmacokinetics of nimesulide. Drugs, v. 46, n. Supp. 1,
p. 73-78, 1993.
PERUCCA, E. Drug interactions with nimesulide. Drugs, v.
46, Suppl. 1, p. 79-82, 1993.
RABASSEDA, X. Nimesulide: A selective cyclooxygenase-
2 inhibitor anti-inflammatory drug. Drugs Today, v. 32,
Suppl. D, p. 1-23, 1992.
SAJEEV, C.; VINAY, G.; ARCHNA, R.; SAHA, R. N. Oral
controlled release formulation of diclofenac sodium by
microencapsulation with ethyl cellulose. J.
Microencapsul., v.19, n. 6, p. 753-60, 2002.
SARAF, S.; DASHORA, K.; SARAF, S. Effect of processing
variables on microparticulate system of aceclofenac. Pak.
J. Pharm. Sci., v. 19, n.1, p.1-6, 2006.
SARAVANAN, M.; BHASKAR, G.; SRINIVASA, RAO.;
DHANARAJ, U. Ibuprofen-loaded ethyl cellulose/
polystyrene microspheres: an approach to get prolonged
drug release with reduced burst effect and low
ethylcellulose content. J. Microencapsul., v. 20, p. 289-
302, 2003.
SINGLA, A.K.; CHAWLA, M.; SINGH, A. Nimesulide:
some pharmaceutical and pharmacological aspects- an
update. J. Pharm. Pharmacol., v. 52, p. 467-486, 2000.
SOPPIMATH, K. S.; KULKARNI, A. R.; AMINABHAVI T.
M.; BHASKAR, C. Cellulose acetate microspheres
prepared by o/w emulsification and solvent evaporation
method, J. Microencapsul., v. 18, p. 811-817, 2001.
Recebido para publicação em 31 de outubro de 2006.
Aceito para publicação em 23 de novembro de 2007.
